| Financial Year |
March 31 2023 |
| Monetary Funds |
114,034,383.02 |
| Held-for-trading Financial Assets |
4,500,000.00 |
| Notes Receivable |
6,918,516.66 |
| Accounts Receivable |
282,947,954.59 |
| Advances to Suppliers |
25,332,039.96 |
| Other Receivables |
6,742,395.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
357,367,868.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,412,991.97 |
| Other Current Assets |
8,072,587.59 |
| Total Current Assets |
1,094,327,885.20 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
29,449,804.50 |
| Fixed Assetes |
296,622,448.03 |
| Under-construction Projects |
14,616,622.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
14,496,160.37 |
| R&D expenses |
-- |
| Goodwill |
491,191,872.58 |
| Long-Term Deferred and Prepaid Expenses |
2,129,438.29 |
| Deferred Income Tax Assets |
24,314,866.57 |
| Other Non-Current Assets |
13,167,791.60 |
| Sub-Total of Non-Current Assets |
896,383,707.82 |
| Total Assets |
1,990,711,593.02 |
| Short-Term Loans |
194,920,416.40 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,393,443.01 |
| Accounts Payable |
191,259,607.73 |
| Accounts Received In Advance |
914,240.09 |
| Employee Compensation Payable |
10,653,940.65 |
| Taxes Payable |
10,960,065.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
155,951,671.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
85,326,655.84 |
| Other Current Liabilities |
2,111,753.87 |
| Sub-Total of Current Liabilities |
666,652,236.34 |
| Long-term Loans |
179,562,386.67 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,372,087.86 |
| Deferred Income Tax Liabilities |
1,448,623.91 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
190,281,279.61 |
| Total Liabilities |
856,933,515.95 |
| Paid-In Capital(Or Share Stock) |
218,296,126.00 |
| Capital Surplus |
481,091,800.67 |
| Surplus Reserve |
30,031,819.95 |
| LESS:Treasury Stock |
42,001,020.23 |
| Undistributed Profits |
411,396,137.07 |
| Minority Stockholder's Interest |
23,513,957.94 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,110,264,119.13 |
| Owner's Equity（Stockholder's Equity） |
1,133,778,077.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,990,711,593.02 |
